123 related articles for article (PubMed ID: 38735696)
1. Clinical outcomes of antithrombin III supplementation in an overt disseminated intravascular coagulation: a longitudinal single-institutional experience and retrospective analysis.
Lee S; Kim J; Ji M; Moon H; Lee W
Ann Palliat Med; 2024 May; 13(3):477-495. PubMed ID: 38735696
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Protective Effects of Recombinant Antithrombin Gamma and Plasma-Derived Antithrombin on Sepsis-Induced Disseminated Intravascular Coagulation and Multiple Organ Failure.
Kuroda H; Masuda Y
Clin Appl Thromb Hemost; 2020; 26():1076029620981630. PubMed ID: 33332196
[TBL] [Abstract][Full Text] [Related]
3. The usefulness of antithrombin activity monitoring during antithrombin supplementation in patients with sepsis-associated disseminated intravascular coagulation.
Iba T; Saitoh D; Gando S; Thachil J
Thromb Res; 2015 May; 135(5):897-901. PubMed ID: 25784136
[TBL] [Abstract][Full Text] [Related]
4. Effects of antithrombin III in patients with disseminated intravascular coagulation diagnosed by newly developed diagnostic criteria for critical illness.
Sawamura A; Gando S; Hayakawa M; Hoshino H; Kubota N; Sugano M
Clin Appl Thromb Hemost; 2009 Oct; 15(5):561-6. PubMed ID: 18840625
[TBL] [Abstract][Full Text] [Related]
5. A randomized, controlled, multicenter trial of the effects of antithrombin on disseminated intravascular coagulation in patients with sepsis.
Gando S; Saitoh D; Ishikura H; Ueyama M; Otomo Y; Oda S; Kushimoto S; Tanjoh K; Mayumi T; Ikeda T; Iba T; Eguchi Y; Okamoto K; Ogura H; Koseki K; Sakamoto Y; Takayama Y; Shirai K; Takasu O; Inoue Y; Mashiko K; Tsubota T; Endo S;
Crit Care; 2013 Dec; 17(6):R297. PubMed ID: 24342495
[TBL] [Abstract][Full Text] [Related]
6. Risk stratification utilizing sequential organ failure assessment (SOFA) score, antithrombin activity, and demographic data in sepsis-associated disseminated intravascular coagulation (DIC).
Iba T; Maier CL; Tanigawa T; Levy JH
Sci Rep; 2023 Dec; 13(1):22502. PubMed ID: 38110515
[TBL] [Abstract][Full Text] [Related]
7. [Antithrombin III for early diagnosis of DIC in sepsis patients: a retrospective analysis with 445 patients].
Xu Y; Zhu R; Sun Y; Li X; Ma X
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Feb; 29(2):127-132. PubMed ID: 28625259
[TBL] [Abstract][Full Text] [Related]
8. Impact of withdrawing antithrombin III administration from management of septic patients with or without disseminated intravascular coagulation.
Kawano S; Uchino S; Endo A; Saito K; Iwai K; Kase Y; Takinami M
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):795-800. PubMed ID: 24806318
[TBL] [Abstract][Full Text] [Related]
9. Supplemental dose of antithrombin use in disseminated intravascular coagulation patients after abdominal sepsis.
Tagami T; Matsui H; Fushimi K; Yasunaga H
Thromb Haemost; 2015 Aug; 114(3):537-45. PubMed ID: 25948492
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and bleeding risk of antithrombin supplementation in septic disseminated intravascular coagulation: a secondary survey.
Iba T; Saitoh D; Wada H; Asakura H
Crit Care; 2014 Sep; 18(5):497. PubMed ID: 25220851
[TBL] [Abstract][Full Text] [Related]
11. Impact of Antithrombin Activity Levels Following Recombinant Antithrombin Gamma Therapy in Patients with Sepsis-Induced Disseminated Intravascular Coagulation.
Akahoshi T; Kaku N; Shono Y; Yamamoto Y; Takahashi K; Iyonaga T; Momii K; Nishihara M; Maki J; Tokuda K; Yamaura K
Clin Appl Thromb Hemost; 2022; 28():10760296221135790. PubMed ID: 36380520
[TBL] [Abstract][Full Text] [Related]
12. Impact of Antithrombin Supplementation and Concomitant Anticoagulation Therapy in Pediatric Patients With Disseminated Intravascular Coagulation.
Nagafuchi H; Eguchi Y; Ikeda T
Clin Appl Thromb Hemost; 2019; 25():1076029619834350. PubMed ID: 30836769
[TBL] [Abstract][Full Text] [Related]
13. Treatment effects of high-dose antithrombin without concomitant heparin in patients with severe sepsis with or without disseminated intravascular coagulation.
Kienast J; Juers M; Wiedermann CJ; Hoffmann JN; Ostermann H; Strauss R; Keinecke HO; Warren BL; Opal SM;
J Thromb Haemost; 2006 Jan; 4(1):90-7. PubMed ID: 16409457
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of Measuring Changes in SOFA Score for the Prediction of 28-Day Mortality in Patients With Sepsis-Associated Disseminated Intravascular Coagulation.
Iba T; Arakawa M; Mochizuki K; Nishida O; Wada H; Levy JH
Clin Appl Thromb Hemost; 2019; 25():1076029618824044. PubMed ID: 30808223
[TBL] [Abstract][Full Text] [Related]
15. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation.
Fourrier F; Chopin C; Huart JJ; Runge I; Caron C; Goudemand J
Chest; 1993 Sep; 104(3):882-8. PubMed ID: 8365305
[TBL] [Abstract][Full Text] [Related]
16. Antithrombin use and mortality in patients with stage IV solid tumor-associated disseminated intravascular coagulation: a nationwide observational study in Japan.
Taniguchi K; Ohbe H; Yamakawa K; Matsui H; Fushimi K; Yasunaga H
BMC Cancer; 2020 Sep; 20(1):867. PubMed ID: 32907555
[TBL] [Abstract][Full Text] [Related]
17. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children.
Fuse S; Tomita H; Yoshida M; Hori T; Igarashi C; Fujita S
Am J Hematol; 1996 Sep; 53(1):18-21. PubMed ID: 8813091
[TBL] [Abstract][Full Text] [Related]
18. [Study on the value of prothrombin time for predicting the severity and prognosis of septic patients].
Bai H; Shen L; Jing L; Liu W; Sun Z; Tang N
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2022 Jul; 34(7):682-688. PubMed ID: 36100403
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulation Therapy Using rh-Thrombomodulin and/or Antithrombin III Agent is Associated With Reduction in in-Hospital Mortality in Septic Disseminated Intravascular Coagulation: A Nationwide Registry Study.
Tanaka K; Takeba J; Matsumoto H; Ohshita M; Annen S; Moriyama N; Nakabayashi Y; Aibiki M
Shock; 2019 Jun; 51(6):713-717. PubMed ID: 31090683
[TBL] [Abstract][Full Text] [Related]
20. A Suggested Link Between Antithrombin Dose and Rate of Recovery from Disseminated Intravascular Coagulation in Patients with Severe Organ Failure.
Kuroda H; Tatsumi H; Sonoda T; Masuda Y
Clin Appl Thromb Hemost; 2022; 28():10760296221080942. PubMed ID: 35187966
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
